An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease (PROTOCOL No. CMX001-351)
This Study is
No Longer Enrolling
Details
Age
Child to Adult
Phase
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Type of Study
Supportive Care
Study ID
Protocol Number: 16-0225
More information available at ClinicalTrials.gov: NCT02596997
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers